You just read:

Mallinckrodt To Acquire InfaCare Pharmaceutical Corporation And Stannsoporfin, Its Proprietary Therapy In Late-Stage Development For Treatment Of Newborns At Risk For Developing Severe Jaundice

News provided by

Mallinckrodt plc

Aug 04, 2017, 07:00 ET